Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind phase II trial of lithium carbonate as add-on therapy in amyotrophic lateral sclerosis
2008-005106-38Phase 2Terminated
- Sponsor
- Hospital Clínico San Carlos
- Start
- Feb 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lithium carbonate in amyotrophic lateral sclerosis (ALS) (2 arms), sponsored by Hospital Clínico San Carlos. Primary endpoints: Change in functional disability progression and Optimal lithium carbonate dose determination. Started Feb 2009; status: terminated.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2008-005106-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005106-38.